(Q86563090)
Statements
Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer (English)
Karim Fizazi
Celestia S Higano
Joel B Nelson
Martin Gleave
Kurt Miller
Thomas Morris
Faith E Nathan
Stuart McIntosh
Kristine Pemberton
Judd W Moul
8 April 2013